Ieq Capital LLC Buys Shares of 193,784 CVS Health Corporation $CVS

Ieq Capital LLC purchased a new position in CVS Health Corporation (NYSE:CVS) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm purchased 193,784 shares of the pharmacy operator’s stock, valued at approximately $20,047,000.

A number of other institutional investors have also made changes to their positions in the stock. Handelsbanken Fonder AB grew its holdings in shares of CVS Health by 83.6% in the 2nd quarter. Handelsbanken Fonder AB now owns 1,089,694 shares of the pharmacy operator’s stock valued at $112,729,000 after buying an additional 496,124 shares during the period. State Street Corp raised its stake in CVS Health by 2.1% during the 4th quarter. State Street Corp now owns 60,183,743 shares of the pharmacy operator’s stock worth $4,776,182,000 after buying an additional 1,245,457 shares during the period. Legal & General Group Plc lifted its holdings in CVS Health by 0.3% during the fourth quarter. Legal & General Group Plc now owns 9,309,182 shares of the pharmacy operator’s stock worth $738,777,000 after acquiring an additional 31,249 shares in the last quarter. Deutsche Bank AG grew its stake in CVS Health by 28.4% in the fourth quarter. Deutsche Bank AG now owns 4,666,495 shares of the pharmacy operator’s stock valued at $370,333,000 after acquiring an additional 1,031,998 shares during the period. Finally, Hussman Strategic Advisors Inc. bought a new stake in shares of CVS Health in the fourth quarter worth about $3,333,000. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Stock Down 0.7%

Shares of CVS Health stock opened at $93.01 on Friday. The business’s 50 day simple moving average is $102.02 and its 200 day simple moving average is $88.86. CVS Health Corporation has a 52-week low of $69.51 and a 52-week high of $110.68. The firm has a market cap of $118.96 billion, a PE ratio of 24.61, a P/E/G ratio of 0.85 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, topping analysts’ consensus estimates of $1.87 by $0.71. The firm had revenue of $106.10 billion during the quarter, compared to the consensus estimate of $100.03 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The business’s revenue was up 7.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, analysts predict that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were issued a dividend of $0.665 per share. The ex-dividend date was Thursday, July 23rd. This represents a $2.66 annualized dividend and a yield of 2.9%. CVS Health’s dividend payout ratio is presently 70.37%.

Analysts Set New Price Targets

Several brokerages recently issued reports on CVS. Barclays boosted their price objective on CVS Health from $106.00 to $108.00 and gave the company an “overweight” rating in a research report on Thursday, August 6th. Robert W. Baird set a $107.00 price target on shares of CVS Health in a research note on Thursday, August 6th. Cantor Fitzgerald upped their price target on shares of CVS Health from $100.00 to $110.00 and gave the company an “overweight” rating in a report on Tuesday, July 7th. Truist Financial increased their price objective on shares of CVS Health from $108.00 to $118.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th. Finally, Royal Bank Of Canada raised their price objective on shares of CVS Health from $107.00 to $113.00 and gave the stock an “outperform” rating in a report on Thursday, July 9th. Twenty-two equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $107.17.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.